HK1257937A1 - 融合蛋白 - Google Patents

融合蛋白

Info

Publication number
HK1257937A1
HK1257937A1 HK19100299.7A HK19100299A HK1257937A1 HK 1257937 A1 HK1257937 A1 HK 1257937A1 HK 19100299 A HK19100299 A HK 19100299A HK 1257937 A1 HK1257937 A1 HK 1257937A1
Authority
HK
Hong Kong
Prior art keywords
fusion protein
fusion
protein
Prior art date
Application number
HK19100299.7A
Other languages
English (en)
Inventor
Rudolf Valenta
Carolin Cornelius
Original Assignee
Viravaxx AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viravaxx AG filed Critical Viravaxx AG
Publication of HK1257937A1 publication Critical patent/HK1257937A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
HK19100299.7A 2015-09-05 2019-01-09 融合蛋白 HK1257937A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15183983.4A EP3138579A1 (en) 2015-09-05 2015-09-05 Fusion protein for use in the treatment of a hepatitis b virus infection
PCT/EP2016/070824 WO2017037280A1 (en) 2015-09-05 2016-09-05 Fusion protein

Publications (1)

Publication Number Publication Date
HK1257937A1 true HK1257937A1 (zh) 2019-11-01

Family

ID=54072694

Family Applications (1)

Application Number Title Priority Date Filing Date
HK19100299.7A HK1257937A1 (zh) 2015-09-05 2019-01-09 融合蛋白

Country Status (15)

Country Link
US (2) US20180244726A1 (zh)
EP (2) EP3138579A1 (zh)
JP (1) JP6830955B2 (zh)
KR (1) KR20180039739A (zh)
CN (1) CN108472356B (zh)
AU (1) AU2016316811B2 (zh)
CA (1) CA2997511C (zh)
ES (1) ES2860803T3 (zh)
HK (1) HK1257937A1 (zh)
MX (1) MX2018002616A (zh)
PH (1) PH12018500468A1 (zh)
RU (1) RU2748643C2 (zh)
UA (1) UA126059C2 (zh)
WO (1) WO2017037280A1 (zh)
ZA (1) ZA201801394B (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3092935A1 (en) * 2018-03-06 2019-09-12 Precigen, Inc. Hepatitis b vaccines and uses of the same
EP4313138A1 (en) 2021-03-30 2024-02-07 Viravaxx AG Sars-cov-2 subunit vaccine
WO2023046898A1 (en) 2021-09-23 2023-03-30 Viravaxx AG Hbv vaccine inducing pres-specific neutralizing antibodies

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1331443C (en) 1987-05-29 1994-08-16 Charlotte A. Kensil Saponin adjuvant
US5057540A (en) 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
AUPM873294A0 (en) 1994-10-12 1994-11-03 Csl Limited Saponin preparations and use thereof in iscoms
UA56132C2 (uk) 1995-04-25 2003-05-15 Смітклайн Бічем Байолоджікалс С.А. Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
PT971739E (pt) 1997-04-01 2004-12-31 Corixa Corp Composicoes aquosas de adjuvante imunologico de monofosforil lipido a
ES2847288T3 (es) * 2008-01-25 2021-08-02 Univ Heidelberg Ruprecht Karls Péptidos derivados de preS hidrófobos modificados del virus de la hepatitis B (VHB) y su uso como vehículos para el suministro específico de compuestos al hígado
US9308251B2 (en) * 2011-06-09 2016-04-12 Biomay Ag Peptide carrier fusion proteins as allergy vaccines

Also Published As

Publication number Publication date
EP3344292A1 (en) 2018-07-11
JP6830955B2 (ja) 2021-02-17
EP3138579A1 (en) 2017-03-08
ZA201801394B (en) 2020-07-29
ES2860803T3 (es) 2021-10-05
UA126059C2 (uk) 2022-08-10
JP2018531911A (ja) 2018-11-01
CN108472356A (zh) 2018-08-31
WO2017037280A1 (en) 2017-03-09
CA2997511A1 (en) 2017-03-09
MX2018002616A (es) 2018-11-09
RU2018112060A (ru) 2019-10-07
AU2016316811A1 (en) 2018-03-22
US20180244726A1 (en) 2018-08-30
AU2016316811B2 (en) 2022-09-22
RU2018112060A3 (zh) 2020-01-29
US20220048955A1 (en) 2022-02-17
CN108472356B (zh) 2022-04-12
EP3344292B1 (en) 2020-12-30
PH12018500468A1 (en) 2018-09-10
KR20180039739A (ko) 2018-04-18
RU2748643C2 (ru) 2021-05-28
CA2997511C (en) 2023-10-17

Similar Documents

Publication Publication Date Title
HK1244019A1 (zh) 融合蛋白
ZA201701810B (en) Sirp-alpha immunoglobulin fusion proteins
GB201509413D0 (en) Fusion protein
EP3188758C0 (en) SIRP-ALPHA ANTIBODY FUSION PROTEINS
HK1232136A1 (zh) 融合蛋白
GB201502305D0 (en) Protein
GB201502306D0 (en) Protein
HK1246315A1 (zh) 細胞因子融合蛋白
GB201504691D0 (en) Fusion protein
GB201515745D0 (en) Proteins
GB201511787D0 (en) Proteins
ZA202003845B (en) Fusion proteins
HK1257937A1 (zh) 融合蛋白
GB201513033D0 (en) Proteins
SG11201606501PA (en) Nanobody-fluorescent protein fusion
GB201602850D0 (en) Fusion proteins
EP3649159C0 (en) FUSION PROTEIN
GB201712792D0 (en) Fusion protein
GB201522610D0 (en) Protein
GB201713537D0 (en) Fusion Polypeptide
IL244857A0 (en) A fusion protein of acetylcholinesterase and the fc region
GB201515744D0 (en) Proteins
GB201503789D0 (en) Fusion polypeptide
GB201515337D0 (en) Protein Expression
GB201503778D0 (en) Proteins